loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 205437 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AMGEN INC (3)

filter

01 TABLET;ORAL (3)

filter

01 RX (3)

filter

01 OTEZLA (3)

filter

01 Yes (3)

URL Supplier Web Content
TABLET; ORAL
20MG
2014-03-21
205437
OTEZLA
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
30MG
2014-03-21
205437
OTEZLA
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
10MG
2014-03-21
205437
OTEZLA
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 205437

Looking for FDA Orange Book APPLICATION 205437 3

19

Amgen Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is APREMILAST, with a corresponding application number 205437.

Regulatory Information RX

With a dosage strength 20MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-03-21

Therapeutic Equivalence (TE) Code AB

18

Amgen Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is APREMILAST, with a corresponding application number 205437.

Regulatory Information RX

With a dosage strength 30MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-03-21

Therapeutic Equivalence (TE) Code AB

17

Amgen Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is APREMILAST, with a corresponding application number 205437.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-03-21

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY